How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. Deodato M, Frustaci AM, Sportoletti P, Laurenti L, et al. Leuk Lymphoma 2022 Mar 27:1-4. doi: 10.1080/10428194.2022.2053532.

Read + Share

Amedeo Smart

Independent Medical Education

Deodato M, Frustaci AM, Sportoletti P, Laurenti L, et al. How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. Leuk Lymphoma 2022 Mar 27:1-4. doi: 10.1080/10428194.2022.2053532.
PMID: 35343363